Summary of histopathologic lesions found in studies where each dose group had two or more of the lesion for each chemical, organ, morphology type, species, route of administration, and dose. Lesions with a statistically significant difference (P<0.05) in incidence between the exposed and control animals are flagged.
CEBS Statistically Analyzed NTP Pathology Lesions Link API: ftp://anonftp.niehs.nih.gov/ntp-cebs/datatype/NTP_Data_Collections/Stati...
Primary tabs
CEBS Statistically Analyzed NTP Pathology Lesions (with Incidence)
Resources
- CEBS Developmental Data
- CEBS Clinical Chemistry Data
- CEBS Microarray Data
- CEBS Genetic Toxicology: Bacterial Mutagenicity Data
- CEBS Genetic Toxicology: Micronucleus Data
- CEBS Gross Pathology Observation Data
- CEBS Hematology Data
- CEBS Histopathology Data
- CEBS Immunology Data
- CEBS In-Life Observation Data
- CEBS PCR Data
- CEBS Reproductive Data
- CEBS Urinalysis Data
- CEBS High Throughput Screening Data (Tox21)
- CEBS Genetic Toxicology: In Vivo Comet Data
- CEBS Genetic Toxicology: In Vitro Micronucleus Data
- NTP Pathology Bioassay Data
- CEBS The ICCVAM Acute Systemic Toxicity Reference List
- CEBS The NICEATM Estrogen Receptor Uterotrophic Assay Data
- CEBS The ICCVAM Skin Sensitization (Murine LLNA) Reference List
- CEBS The ICCVAM Androgen Receptor Agonist Reference List
- CEBS Ames Conclusions
- CEBS Bioassay Genetox Conclusion Dataset
- CEBS Microarray Dataset
- CEBS Drosophila Germ Cell Mutagenicity
- CEBS Mammalian Cell Cytogenetics
- CEBS Mammalian Cell Mutagenicity
- CEBS Rodent Cytogenetics
- CEBS In Vivo Micronucleus
- CEBS Benchmark Dose Analysis for Neoplastic and Non-neoplastic Lesions
- CEBS Hallmark Gene Sets Annotations
- CEBS Toxicity Estimates of the ToxCast Chemicals in C. elegans and Zebrafish
- CEBS Evaluation of Androgen Receptor Agonists Dataset
- CEBS Evaluation of Androgen Receptor Antagonists
- CEBS Tox21 Androgen Receptor Assays and Androgen Receptor Pathway Model Dataset
- CEBS Comet Assay Conclusions
- CEBS In Vitro Micronucleus
- CEBS Statistically Analyzed NTP Pathology Lesions (with Incidence)
- CEBS Tox21 Phase 2 Purity